相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Apoptin Regulates Apoptosis and Autophagy by Modulating Reactive Oxygen Species (ROS) Levels in Human Liver Cancer Cells
Yiquan Li et al.
FRONTIERS IN ONCOLOGY (2020)
Mediators of cachexia in cancer patients
Josep M. Argiles et al.
NUTRITION (2019)
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Vaishali Aggarwal et al.
BIOMOLECULES (2019)
ROS as a novel indicator to predict anticancer drug efficacy
Tarek Zaidieh et al.
BMC CANCER (2019)
Body composition as a predictor of toxicity after treatment with eribulin for advanced soft tissue sarcoma
Hiroshi Kobayashi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Molecular regulation of skeletal muscle mass and the contribution of nitric oxide: A review
Jun Kobayashi et al.
FASEB BIOADVANCES (2019)
Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy
V. E. Baracos et al.
ANNALS OF ONCOLOGY (2018)
Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia
Johanna Abrigo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Mechanistic Role of Reactive Oxygen Species and Therapeutic Potential of Antioxidants in Denervation- or Fasting-Induced Skeletal Muscle Atrophy
Jiaying Qiu et al.
FRONTIERS IN PHYSIOLOGY (2018)
Resveratrol Ameliorates Palmitate-Induced Inflammation in Skeletal Muscle Cells by Attenuating Oxidative Stress and JNK/NF-κB Pathway in a SIRT1-Independent Mechanism
Asie Sadeghi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
TNF-α and cancer cachexia: Molecular insights and clinical implications
Hetal J. Patel et al.
LIFE SCIENCES (2017)
Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation
Brandon N. VanderVeen et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Skeletal Muscle as an Endocrine Organ: The Role of Myokines in Exercise Adaptations
Christoph Hoffmann et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Febuxostat protects rats against lipopolysaccharide-induced lung inflammation in a dose-dependent manner
Alaa N. A. Fahmi et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2016)
Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer
B. H. L. Tan et al.
EJSO (2015)
The xanthine oxidase inhibitor Febuxostat reduces tissue uric acid content and inhibits injury-induced inflammation in the liver and lung
Hiroshi Kataoka et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Hypoxia and free radicals: Role in tumor progression and the use of engineering-based platforms to address these relationships
Abigail Hielscher et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis
Shulin Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Causality and Chance in the Development of Cancer
Lucio Luzzatto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Febuxostat improves outcome in a rat model of cancer cachexia
Masaaki Konishi et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation
Martin Pal et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Vitamin E in Sarcopenia: Current Evidences on Its Role in Prevention and Treatment
Shy Cian Khor et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice
Johji Nomura et al.
SCIENTIFIC REPORTS (2014)
Tumor-associated fibroblast-conditioned medium promotes tumor cell proliferation and angiogenesis
L. N. Xu et al.
GENETICS AND MOLECULAR RESEARCH (2013)
Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients
Ayse Durnali et al.
MEDICAL ONCOLOGY (2013)
Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes
Estibaliz Castillero et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress
Hidetoshi Tsuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Kenneth C. H. Fearon et al.
CELL METABOLISM (2012)
Oxidative stress and disuse muscle atrophy: cause or consequence?
Scott K. Powers et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2012)
Editorial update on emerging drugs for cancer cachexia
Kate T. Murphy et al.
EXPERT OPINION ON EMERGING DRUGS (2012)
Polyphenols decreased liver NADPH oxidase activity, increased muscle mitochondrial biogenesis and decreased gastrocnemius age-dependent autophagy in aged rats
Caroline Laurent et al.
FREE RADICAL RESEARCH (2012)
Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia
Jochen Springer et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Molecular and cellular mechanisms of skeletal muscle atrophy: an update
Alessandro Fanzani et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2012)
Febuxostat inhibition of endothelial-bound XO: Implications for targeting vascular ROS production
Umair Z. Malik et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Cancer cachexia
Michael J. Tisdale
CURRENT OPINION IN GASTROENTEROLOGY (2010)
Interleukin 6 as a Key Regulator of Muscle Mass during Cachexia
James A. Carson et al.
EXERCISE AND SPORT SCIENCES REVIEWS (2010)
Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes
Michael Menconi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
分享论文
